| 1. |
Khan A, Agarwal R. Pulmonary alveolar proteinosis. Rrepir Care, 2011, 56(7): 1016-1028.
|
| 2. |
Carey B, Trapnell BC. The molecular basis of pulmonary alveolar proteinosis. Clin Immunol, 2010, 135(2): 223-235.
|
| 3. |
Seymour JF, Presneill JJ. Pulmonary alveolar proteinosis: progress in the first 44 years. Am J Respir Crit Care Med, 2002, 166(2): 215-235.
|
| 4. |
李妍, 田欣倫, 徐凱峰, 等. 特發性肺泡蛋白沉積癥患者血清生物標志物的臨床意義. 中華結核和呼吸雜志, 2014, 37(7): 497-501.
|
| 5. |
Antoniu SA. GM-CSF pathway correction in pulmonary alveolar proteinosis. Expert Opin Biol Ther, 2010, 10(9): 1357-1365.
|
| 6. |
Tazawa R, Trapnell BC, Inoue Y, et al. Inhaled granulocyte/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis. Am J Respir Crit Care Med, 2010, 181(12): 1345-1354.
|
| 7. |
Seymour JF, Presneill JJ, Schoch OD, et al. Therapeutic dfficacy of granulocyte-macrophage colony-stimulating factor in patients with idiopathic acquired alveolar proteinosis. Am J Respir Crit Care Med, 2001, 163(2): 524-531.
|
| 8. |
Venkateshiah SB, Yan TD, Bonfield TL, et al. An open-label trial of granulocyte macrophage colony stimulating factor therapy for moderate symptomatic pulmonary alveolar proteinosis. Chest, 2006, 130(1): 227-237.
|
| 9. |
Wylam ME, Ten R, Prakash UB, et al. Aerosol granulocyte-macrophage colony-stimulating factor for pulmonary alveolar proteinosis. Eur Respir J, 2006, 27(3): 585-593.
|
| 10. |
Khan A, Agarwal R, Aggarwal AN. Effectiveness of granulocyte-macrophage colony-stimulating factor therapy in autoimmune pulmonary alveolar proteinosis: a meta-analysis of observational studies. Chest, 2012, 141(5): 1273-1283.
|
| 11. |
Uchida K, Beck DC, Yamamoto T, et al. GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis. N Engl J Med, 2007, 356(6): 547-549.
|
| 12. |
Yu HY, Sun XF, Wang YX, et al. Whole lung lavage combined with granulocyte-macrophage colony stimulating factor inhalation for an adult case of refractory pulmonary alveolar proteinosis. BMC Pulm Med, 2014, 14: 87.
|
